Legal and Confidentiality (2017) | David Kan, MD

This presentation is part of the Addiction Medicine Review Course 2017, an overview of the core elements of addiction medicine, presented by top experts in the field. Together with the other presentation it can serve as a broad review for clinicians, a review of the basics for newcomers, or a starting point for those preparing to sit for the Board of Addiction Exam.

Target Audience

  • Addiction medicine specialists who want an overview of the latest developments in the field and their relevance to clinical practice
  • Primary care clinicians who want to get a better understanding of addiction and manage patients with addictions in their practice
  • Public health officials who want an understanding of the current state of addiction treatment
  • Non-physicians who are involved in the treatment of addiction

Learning Objectives

At the end of this activity the learner should be more competent in applying appropriate ethical and confidentiality principles, laws and regulations to the practice of addiction medicine, including the following: 

  1. HIPPA regulations pertaining to confidentiality, for under-age minor versus adult patients, specifically concerning addiction and mental health disorders. 
  2. Concepts and regulations relating to record-keeping, patient privacy and security of records, including the limitations and privacy expectations of 42CFR in integrated settings.
  3. Discussion of ethical issues specific to the field of addiction medicine.
Course summary
Available credit: 
  • 0.75 AMA Category 1
  • 0.75 Attendance
Course opens: 
Course expires: 

David Kan, MD
Dr. David Kan is Medical Director of Bright Heart Health, the first of its kind addiction telehealth treatment program. Dr. Kan is also a psychiatrist in private practice in addiction, forensic and general psychiatry. Dr. Kan is the President-Elect of CSAM and the chair of the opioid committee. Dr. Kan has served CSAM as a member of the Executive Council since 2011 and has written numerous documents affecting physician practice. He has helped insurance companies drop prior authorization requirements for Medication Assisted Treatment. He is active in political advocacy on behalf of all of our patients.


Dr. Kan has no relevant financial relationships

The California Society of Addiction Medicine (CSAM) is accredited by the Institute for Medical Quality/California Medical Association to provide continuing medical education for physicians. CSAM takes responsibility for the content, quality and scientific integrity of this CME activity.

CSAM designates this edduring internet-based educational activity for a maximum of .75 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

This credit may also be applied to the CMA Certification in Continuing Medical Education.

Available Credit

  • 0.75 AMA Category 1
  • 0.75 Attendance


Please login or register to take this course.